More significantly, Horvath’s group discovered in vitro that islet amyloid polypeptide (IAPP), a primary pathogenic deposit in T2DM patients, promotes the accumulation of alpha-synuclein amyloid (13). This evidence concerns the gene IAPP and type 2 diabetes mellitus.